黑料网

Journal of Pharmacokinetics & Experimental Therapeutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yoshio Tachiura

Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Ghutania, Japan
Publications

Medication that Reduces Cholesterol by Preventing the body's Production of Cholesterol

The Smith-Lemli-Opitz syndrome (SLOS) is a multiple malformation/mental retardation syndrome caused by a deficiency of the enzyme 7 dehydrocholesterol Δ7-reductase. This enzyme converts 7-dehydrocholesterol (7-DHC) to cholesterol in the last step in cholesterol biosynthesis. The pathology of this condition may result from two different factors... Read More»

Yoshio Tachiura

: J Pharmacokinet Exp Ther 2023, 7:174

10.4172/jpet.1000174

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top